6,8-bis-benzylsulfanyl-octanoic acid | |
---|---|
Trade Name | |
Orphan Indication | Pancreatic Cancer |
USA Market Approval | USA |
USA Designation Date | 2006-02-06 00:00:00 |
Sponsor | Cornerstone Pharmaceuticals, Inc.;25 Health Science Drive;Stony Brook, New York, 11790 |